Synthesis of substituted N-[3-(3-methoxyphenyl)propyl] amides as highly potent MT2-selective melatonin ligands

Bioorganic and Medicinal Chemistry Letters

Volumn 20, Issue 8, 2010, Pages 2582-2585

  Hu, Yueqing ^a   Ho, Maurice K C ^a   Chan, King H ^a   New, David C ^a   Wong, Yung H ^a  

^a HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Hong Kong)

Author keywords

Ligand; Melatonin; SAR

Indexed keywords

AMIDE; BENZENE DERIVATIVE; LIGAND; MELATONIN 1 RECEPTOR; MELATONIN 2 RECEPTOR;

ANIMAL CELL; ARTICLE; CHO CELL; DRUG POTENCY; DRUG RECEPTOR BINDING; DRUG SCREENING; DRUG SYNTHESIS; NONHUMAN; RECEPTOR AFFINITY; STRUCTURE ACTIVITY RELATION;

EID: 77950040001     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2010.02.084     Document Type: Article

References (28)

1. Reiter R.J. Endocrinol. Rev. 12 (1991) 151
2. Kennaway D.J., and Wright H. Curr. Top. Med. Chem. 2 (2002) 199
3. Blask D.E., Sauer L.A., and Dauchy R.T. Curr. Top. Med. Chem. 2 (2002) 113
4. Dubocovich M.L., and Markowska M. Endocrine 27 (2005) 101
5. Pandi-Perumal S.R., Trakht I., Srinivasan V., Spence D.W., Maestroni G.J.M., Zisapel N., and Cardinali D.P. Prog. Neurobiol. 85 (2008) 335
6. Dubocovich M.L., Rivera-Bermudez M.A., Gerdin M.J., and Masana M.I. Front. Biosci. 8 (2003) d1093
7. New D.C., Tsim S.T., and Wong Y.H. Neurosignals 12 (2003) 59
8. Ekmekcioglu C. Biomed. Pharmacother. 60 (2006) 97
9. Liu C., Weaver D.R., Jin X., Shearman L.P., Pieschl R.L., Gribkoff V.K., and Reppert S.M. Neuron 19 (1997) 91
10. Jin X., von Gall C., Pieschl R.L., Gribkoff V.K., Stehle J.H., Reppert S.M., and Weaver D.R. Mol. Cell Biol. 23 (2003) 1054
11. Stehle J., Vanecek J., and Vollrath L. J. Neural Transm. 78 (1989) 173
12. Buscemi N., Vandermeer B., Hooton N., Pandya R., Tjosvold L., Hartling L., Vohra S., Klassen T.P., and Baker G. BMJ 332 (2006) 385
13. Brzezinski A., Vangel M.G., Wurtman R.J., Norrie G., Zhdanova I., Ben-Shushan A., and Ford I. Sleep Med. Rev. 9 (2005) 41
14. Fisher S.P., and Sugden D. Neurosci. Lett. 457 (2009) 93
15. Hunt A.E., Al-Ghoul W.M., Gillette M.U., and Dubocovich M.L. Am. J. Physiol. Cell Physiol. 280 (2001) C110
16. Dubocovich M.L., Hudson R.L., Sumaya I.C., Masana M.I., and Manna E. J. Pineal Res. 39 (2005) 113
17. Claustrat B., Brun J., and Chazot G. Sleep Med. Rev. 9 (2005) 11
18. Mor M., Plazzi P.V., Spadoni G., and Tarzia G. Curr. Med. Chem. 6 (1999) 501
19. Zlotos D.P. Arch. Pharmacol. Chem. Life Sci. 338 (2005) 229
20. Garratt P.J., and Tsotinis A. Min-Rev. Med. Chem. 7 (2007) 1075
21. Boutin J.A., Audinot V., Ferry G., and Delagrange P. Trends Pharmacol. Sci. 26 (2005) 412
22. Mody S.M., Hu Y., Ho M.K.C., and Wong Y.H. Recent Pat CNS Drug Discovery 2 (2007) 241
23. Garratt P.J., Travard S., Vonhoff S., Tsotinis A., and Sudgen D. J. Med. Chem. 39 (1996) 1797
24. Takaki, K. S.; Karageorge, G. N.; Keavy, D. J.; Parker, M. F.; Watson, B. T. Eur. Pat Appl. EP 706994, 1996.
25. Pegurier C., Curtet S., Nicolas J.P., Boutin J.A., Delagrange P., Renard P., and Langlois M. Bioorg. Med. Chem. 8 (2000) 163
26. Sun L.-Q., Takaki K., Chen J., Bertenshaw S., Iben L., Mahle C.D., Ryan E., Wu D., Gao Q., and Xu C. Bioorg. Med. Chem. Lett. 15 (2005) 1345
27. 13C NMR, ESI-MS, etc.
28. i values were calculated using the Cheng-Prusoff equation.